The FDA has issued a recall of over 140,000 bottles of cholesterol medication due to "failed dissolution specifications." ...
The Food and Drug Administration recalled hundreds of thousands of bottles of the cholesterol drug Atorvastatin Calcium ...
The FDA said that over 140,000 bottles of the Lipitor generic potentially failed to meet "dissolution specifications." ...
Nearly 142,000 bottles of atorvastatin calcium tablets recalled nationwide • Faulty dissolution may limit drug absorption and ...
Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.
FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs ...
The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets ...
The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...
Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed ...
TipRanks on MSN
Mycophenolate Pregnancy Registry: Key Insights for Investors
The study focuses on mycophenolate, a medication used primarily in organ transplantation and autoimmune diseases, to monitor pregnancy outcomes and potential birth defects. This is part of a Risk ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback